A traveling female patient with a two‑week history of generalized itching, who started metoprolol (beta‑blocker) two months ago and noticed worsening itching after yesterday’s dose while taking loratadine (Claritin), should metoprolol be discontinued and how should the itching be managed?

Discontinue Metoprolol and Manage as Drug-Induced Pruritus

Given the temporal relationship between metoprolol initiation (2 months ago) and the onset of generalized itching (2 weeks duration), with worsening after yesterday's dose, metoprolol should be discontinued after a risk-benefit discussion with the patient, and the itching managed symptomatically while monitoring for resolution.

Clinical Reasoning

Drug-Induced Pruritus Assessment

The timeline is highly suggestive of drug-induced pruritus:

• Metoprolol started 2 months ago
• Itching began 2 weeks ago (well within the typical latency period for beta-blocker cutaneous reactions)
• Worsening noted after yesterday's dose
• No visible skin lesions described (consistent with drug-induced pruritus without rash)

Beta-blockers, including metoprolol, are documented causes of cutaneous reactions. Historical data shows propranolol (a related beta-blocker) causes psoriasiform eruptions with an average latency of 10 months, though reactions can occur earlier 1. Urticaria reactions to beta-blockers, while rare, are well-documented 2, 3.

Discontinuation Strategy

The British Association of Dermatologists guidelines explicitly recommend: "A trial of cessation of medications should be undertaken, if the risk vs. benefit analysis is acceptable to both clinician and patient" for drug-induced generalized pruritus 4.

However, metoprolol cannot be abruptly discontinued due to FDA warnings about severe exacerbation of angina, myocardial infarction, and ventricular arrhythmias in patients with coronary artery disease 5. The FDA label mandates: "When discontinuing chronically administered metoprolol, particularly in patients with coronary artery disease, the dosage should be gradually reduced over a period of 1 to 2 weeks" 5.

Critical decision point: Determine if this patient has coronary artery disease or is taking metoprolol solely for hypertension. If hypertension only, discontinuation can be more rapid but still should be tapered over several days to a week to avoid rebound hypertension.

Symptomatic Management During Taper

While tapering metoprolol, implement antipruritic therapy:

First-line symptomatic treatment 4:

• Continue loratadine 10 mg daily (already started)
• Add emollients liberally and frequently
• Consider adding an H2-antagonist (cimetidine) in combination with the H1-antihistamine for enhanced effect

If inadequate response after 3-5 days:

• Switch to or add fexofenadine 180 mg daily (non-sedating alternative)
• Consider cetirizine 10 mg if mild sedation acceptable
• Add topical menthol or clobetasone butyrate to affected areas 4

Second-line options if pruritus persists 4:

• Gabapentin (start 100-300 mg at bedtime, titrate as needed)
• Mirtazapine 7.5-15 mg at bedtime
• Pregabalin as alternative to gabapentin

Alternative Antihypertensive

Once metoprolol is discontinued, substitute with a non-beta-blocker antihypertensive:

• ACE inhibitor (e.g., lisinopril)
• Angiotensin receptor blocker (ARB)
• Calcium channel blocker (e.g., amlodipine)

If a beta-blocker is absolutely required for specific cardiac indications, bisoprolol has been successfully used as an alternative when propranolol caused urticaria 2. However, cross-reactivity between beta-blockers exists, so this should only be attempted if beta-blockade is medically essential and after complete resolution of symptoms.

Common Pitfalls to Avoid

1. Never abruptly stop metoprolol - Risk of rebound hypertension, angina, or MI 5
2. Don't assume all itching is allergic - Beta-blockers can worsen pre-existing urticaria and anaphylaxis through beta-receptor blockade 3
3. Avoid sedating antihistamines long-term - Associated with dementia risk in elderly patients 4
4. Don't use topical capsaicin or calamine - Not recommended for generalized pruritus 4

Expected Timeline

• Itching should improve within 1-5 weeks after complete discontinuation based on beta-blocker cutaneous reaction data 1
• If symptoms persist beyond 4-6 weeks post-discontinuation, investigate other causes of generalized pruritus (thyroid, renal, hepatic, hematologic)
• The patient's traveling status may complicate follow-up; ensure clear instructions and access to care

Monitoring

• Blood pressure during taper (daily if possible)
• Symptom diary for itching severity
• If no improvement after complete discontinuation and 2-4 weeks washout, refer to dermatology or allergy for further evaluation 4